SCHEMBL131732

SCHEMBL131732

C=C(C)CCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3251595 0.97
SCHEMBL921645 0.80
SCHEMBL467091 0.78
SCHEMBL83558 0.76
SCHEMBL23030369 0.76 PAOX (0.56)
SCHEMBL466758 0.76 PAOX (0.56)
SCHEMBL18807954 0.76 PAOX (0.56)
SCHEMBL22561808 0.76 PAOX (0.56)
SCHEMBL466947 0.76 PAOX (0.56)
SCHEMBL29335063 0.76 PAOX (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119454920-A Complex enzyme nanogel and preparation method and application thereof 厦门上佳源生物科技有限公司 2025-02-18 CN claimed
CN-113121751-A High-adaptability concrete superplasticizer, preparation method and application thereof 江苏苏博特新材料股份有限公司 2021-07-16 CN claimed
CN-110201240-B Modified extracellular matrix hydrogel, preparation method and application thereof, and tissue engineering material 中山大学 2020-06-30 CN claimed
CN-107163191-B Anti-mud polycarboxylic acid high-efficiency water reducing agent and preparation method thereof 江苏奥莱特新材料股份有限公司 2020-03-17 CN claimed
CN-107265907-B Amphoteric antibacterial polycarboxylic acid high-efficiency water reducing agent and preparation method thereof 江苏奥莱特新材料股份有限公司 2020-02-04 CN claimed
CN-110201240-A Modified cell epimatrix hydrogel and its preparation method and application, tissue engineering material 中山大学 2019-09-06 CN claimed
US-12359197-B2 Compositions and methods for editing nucleic acids in cells utilizing oligonucleotides ETAGEN PHARMA, INC. (US) 2025-07-15 US disclosed
CN-119454920-A Complex enzyme nanogel and preparation method and application thereof 厦门上佳源生物科技有限公司 2025-02-18 CN disclosed
EP-4371979-A1 FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT Kumiai Chemical Industry Co., Ltd. (JP) 2024-05-22 EP disclosed
EP-4372091-A2 COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES Woolf, Tod M. (US) 2024-05-22 EP disclosed
EP-3230445-B1 COMPOSITIONS AND METHODS FOR EDITING NUCLEIC ACIDS IN CELLS UTILIZING OLIGONUCLEOTIDES WOOLF TOD M (US) 2024-01-24 EP disclosed
EP-3253752-B1 [9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO-[2,1-A]ISOQUINOLIN-2-YL]METHANOL AND COMPOUNDS, COMPOSITIONS AND METHODS RELATING THERETO NEUROCRINE BIOSCIENCES INC (US) 2023-08-16 EP disclosed
CN-114957088-B Preparation method of azabicyclo drug intermediate and salt thereof 甘肃皓天科技股份有限公司 2023-06-30 CN disclosed
EP-1512397-A1 O-SUBSTITUTED HYDROXYARYL DERIVATIVES Institute of Medicinal Molecular Design, Inc. (JP) 2005-03-09 EP disclosed
EP-1510210-A1 IMMUNITY-RELATED PROTEIN KINASE INHIBITORS Institute of Medicinal Molecular Design, Inc. (JP) 2005-03-02 EP disclosed
EP-1510207-A1 THERAPEUTIC DRUG FOR DIABETES Institute of Medicinal Molecular Design, Inc. (JP) 2005-03-02 EP disclosed
US-20040259877-A1 Inhibitors against the production and release of inflammatory cytokines INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2004-12-23 US disclosed
EP-1352650-A1 INHIBITORS AGAINST THE PRODUCTION AND RELEASE OF INFLAMMATORY CYTOKINES Institute of Medicinal Molecular Design, Inc. (JP) 2003-10-15 EP disclosed
CN-1071331-A The hair spray compositions that contains the ion styling polymer PROCTER & GAMBLE (US) 1993-04-28 CN disclosed
US-4622368-A Plasticized polyetherimide blends GENERAL ELECTRIC COMPANY (US) 1986-11-11 US disclosed